| Symbol |
Name |
|
ABI1
|
abl-interactor 1
|
|
ACTN1
|
actinin, alpha 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AIRE
|
autoimmune regulator
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANXA1
|
annexin A1
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATF1
|
activating transcription factor 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BCL2L1
|
BCL2-like 1
|
|
BRAP
|
BRCA1 associated protein
|
|
BRD1
|
bromodomain containing 1
|
|
BSG
|
basigin (Ok blood group)
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CAB39L
|
calcium binding protein 39-like
|
|
CAMKK1
|
calcium/calmodulin-dependent protein kinase kinase 1, alpha
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD300E
|
CD300e molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
E2F7
|
E2F transcription factor 7
|
|
EDN1
|
endothelin 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENG
|
endoglin
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
GATA2
|
GATA binding protein 2
|
|
GMPR2
|
guanosine monophosphate reductase 2
|
|
GNLY
|
granulysin
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GSN
|
gelsolin
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HDC
|
histidine decarboxylase
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA10
|
homeobox A10
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IGF2
|
insulin-like growth factor 2
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL16
|
interleukin 16
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0100
|
KIAA0100
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR146A
|
microRNA 146a
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR424
|
microRNA 424
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT1A
|
metallothionein 1A
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NCK1
|
NCK adaptor protein 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PLAC8
|
placenta-specific 8
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRTN3
|
proteinase 3
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PURA
|
purine-rich element binding protein A
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
SELPLG
|
selectin P ligand
|
|
SEPT9
|
septin 9
|
|
SIRT1
|
sirtuin 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SP1
|
Sp1 transcription factor
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SYK
|
spleen tyrosine kinase
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THEMIS2
|
thymocyte selection associated family member 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TP53
|
tumor protein p53
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
